R. Abdelnabi, J. Neyts, and L. Delang, Towards antivirals against chikungunya virus, Antiviral Research, vol.121, pp.59-68, 2015.
DOI : 10.1016/j.antiviral.2015.06.017

R. Abdelnabi, J. Neyts, and L. Delang, Chikungunya virus infections: time to act, time to treat, Current Opinion in Virology, vol.24, pp.25-30, 2017.
DOI : 10.1016/j.coviro.2017.03.016

T. Ahola and D. G. Karlin, Sequence analysis reveals a conserved extension in the capping enzyme of the alphavirus supergroup, and a homologous domain in nodaviruses, Biology Direct, vol.299, issue.5881, p.16, 2015.
DOI : 10.1038/299371a0

I. C. Albulescu, M. Van-hoolwerff, L. A. Wolters, E. Bottaro, C. Nastruzzi et al., Suramin inhibits chikungunya virus replication through multiple mechanisms, Antiviral Research, vol.121, pp.39-46, 2015.
DOI : 10.1016/j.antiviral.2015.06.013

F. J. Burt, M. S. Rolph, N. E. Rulli, S. Mahalingam, and M. T. Heise, Chikungunya: a re-emerging virus, The Lancet, vol.379, issue.9816, pp.662-671, 2012.
DOI : 10.1016/S0140-6736(11)60281-X

F. Burt, W. Chen, and S. Mahalingam, Chikungunya virus and arthritic disease, The Lancet Infectious Diseases, vol.14, issue.9, pp.789-790, 2014.
DOI : 10.1016/S1473-3099(14)70869-2

A. Chakraborty, S. Dey, S. Sawoo, N. N. Adarsh, and A. Sarkar, Regioselective 1,3-Dipolar Cycloaddition Reaction of Azides with Alkoxy Alkynyl Fischer Carbene Complexes, Organometallics, vol.29, issue.23, pp.6619-6622, 2010.
DOI : 10.1021/om1009523

Y. Chen, Y. Chen, C. Tseng, C. Liang, C. Yang et al., ]quinoline Derivatives as Selective and Orally Active Compounds against Non-Small-Cell Lung Cancers, Journal of Medicinal Chemistry, vol.54, issue.13, 2011.
DOI : 10.1021/jm200046z

K. C. Ching, Y. W. Kam, A. Merits, L. F. Ng, and C. L. Chai, ]pyrrole 5-Carboxamides as Potent Inhibitors of Alphaviruses, Journal of Medicinal Chemistry, vol.58, issue.23, pp.9196-9213, 2015.
DOI : 10.1021/acs.jmedchem.5b01047

T. Couderc and M. Lecuit, Chikungunya virus pathogenesis: From bedside to bench, Antiviral Research, vol.121, pp.120-131, 2015.
DOI : 10.1016/j.antiviral.2015.07.002

URL : https://hal.archives-ouvertes.fr/pasteur-01204785

P. Kaur and J. J. Chu, Chikungunya virus: an update on antiviral development and challenges, Drug Discovery Today, vol.18, issue.19-20, pp.969-983, 2013.
DOI : 10.1016/j.drudis.2013.05.002

S. C. Kuo, Y. M. Wang, Y. J. Ho, T. Y. Chang, Z. Z. Lai et al., Suramin treatment reduces chikungunya pathogenesis in mice, Antiviral Research, vol.134, pp.89-96, 2016.
DOI : 10.1016/j.antiviral.2016.07.025

URL : https://doi.org/10.1016/j.antiviral.2016.07.025

R. Lani, P. Hassandarvish, M. Shu, W. H. Phoon, J. J. Chu et al., Antiviral activity of selected flavonoids against Chikungunya virus, Antiviral Research, vol.133, pp.50-61, 2016.
DOI : 10.1016/j.antiviral.2016.07.009

C. Li, J. Guill-en, N. Rabah, A. Blanjoie, F. Debart et al., ABSTRACT, Journal of Virology, vol.89, issue.16, pp.8292-8303
DOI : 10.1128/JVI.00599-15

URL : https://hal.archives-ouvertes.fr/hal-00232969

L. Presti, A. Cella, E. Angeletti, S. Ciccozzi, and M. , Molecular epidemiology, evolution and phylogeny of Chikungunya virus: An updating review, Infection, Genetics and Evolution, vol.41, pp.270-278, 2016.
DOI : 10.1016/j.meegid.2016.04.006

P. Mishra, A. Kumar, P. Mamidi, S. Kumar, I. Basantray et al., Inhibition of Chikungunya Virus Replication by 1-[(2-Methylbenzimidazol-1-yl) Methyl]-2-Oxo-Indolin-3-ylidene] Amino] Thiourea(MBZM-N-IBT), IBT). Sci. Rep. 6, 2016.
DOI : 10.1128/AAC.49.11.4437-4442.2005

URL : http://www.nature.com/articles/srep20122.pdf

A. Miyashita, K. Fujimoto, T. Okada, and T. Higashino, Synthesis of fused pyrimidinones by reaction of aminoarene-carboxamide with esters; Preparation, pyrimidinones, and quinazolones, pp.3-5, 1996.

C. Pergola, N. Gaboriaud-kolar, N. Jest?-adt, S. K?-onig, M. Kritsanida et al., Indirubin Core Structure of Glycogen Synthase Kinase-3 Inhibitors as Novel Chemotype for Intervention with 5-Lipoxygenase, Journal of Medicinal Chemistry, vol.57, issue.9, pp.3715-3723, 2014.
DOI : 10.1021/jm401740w

A. M. Powers, Risks to the Americas associated with the continued expansion of chikungunya virus, Journal of General Virology, vol.123, issue.1, pp.1-5, 2015.
DOI : 10.1016/j.actatropica.2012.03.004

A. A. Rashad, S. Mahalingam, and P. A. Keller, Chikungunya Virus: Emerging Targets and New Opportunities for Medicinal Chemistry, Journal of Medicinal Chemistry, vol.57, issue.4, 2013.
DOI : 10.1021/jm400460d

V. Rougeron, I. C. Sam, M. Caron, D. Nkoghe, E. Leroy et al., Chikungunya, a paradigm of neglected tropical disease that emerged to be a new health global risk, Journal of Clinical Virology, vol.64, pp.144-152, 2015.
DOI : 10.1016/j.jcv.2014.08.032

S. D. Thiberville, N. Moyen, L. Dupuis-maguiraga, A. Nougairede, E. A. Gould et al., Chikungunya fever: Epidemiology, clinical syndrome, pathogenesis and therapy, Antiviral Research, vol.99, issue.3, pp.345-370, 2013.
DOI : 10.1016/j.antiviral.2013.06.009

M. M. Thiboutot, S. Kannan, O. U. Kawalekar, D. J. Shedlock, A. S. Khan et al., Chikungunya: A Potentially Emerging Epidemic?, PLoS Neglected Tropical Diseases, vol.28, issue.4, p.623, 2010.
DOI : 10.1371/journal.pntd.0000623.t002

URL : https://doi.org/10.1371/journal.pntd.0000623

F. S. Varghese, B. Thaa, S. N. Amrun, D. Simarmata, K. Rausalu et al., ABSTRACT, Journal of Virology, vol.90, issue.21, pp.9743-9757, 2016.
DOI : 10.1128/JVI.01382-16

K. Vougogiannopoulou, Y. Ferandin, K. Bettayeb, V. Myrianthopoulos, O. Lozach et al., Soluble 3???,6-Substituted Indirubins with Enhanced Selectivity toward Glycogen Synthase Kinase -3 Alter Circadian Period, Journal of Medicinal Chemistry, vol.51, issue.20, pp.6421-6431, 2008.
DOI : 10.1021/jm800648y

URL : http://europepmc.org/articles/pmc2717725?pdf=render

Y. Wang, J. Lu, C. Lin, Y. Chin, T. Wu et al., Antiviral activities of niclosamide and nitazoxanide against chikungunya virus entry and transmission, Antiviral Research, vol.135, pp.81-90, 2016.
DOI : 10.1016/j.antiviral.2016.10.003

S. C. Weaver and N. L. Forrester, Chikungunya: Evolutionary history and recent epidemic spread, Antiviral Research, vol.120, pp.32-39, 2015.
DOI : 10.1016/j.antiviral.2015.04.016